Clinical Decision Making Regarding Benzodiazepine Use in PTSD Treatment
Running Title: Clinical Decision Making
Nancy C. Bernardy PhD1, Erin Barnett PhD2, Brian C. Lund PharmD3, Bruce Alexander
PharmD4, Louise E. Parker PhD5,6 Aaron Jenkyn BA7, Matthew J. Friedman MD, PhD8
1 Health Science Specialist, National Center for PTSD, Veterans Affairs Medical Center, White River Junction, VT and Associate Professor, Department of Psychiatry, The Geisel School of Medicine at Dartmouth, Hanover, NH
2 Assistant Professor of Psychiatry and The Dartmouth Institute for Health Policy and Clinical Practice, The Geisel School of Medicine at Dartmouth, Hanover, NH
3 MS, Core Investigator, Center for Comprehensive Access & Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, IA
4 Contract Data Manager, Center for Comprehensive Access & Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, IA
5 University of Massachusetts Boston, Department of Management, Boston, MA
6 VA Quality Enhancement Research Initiative (QUERI) Program for Team-Based Behavioral Health, Department of Veterans Affairs
7 Research Coordinator, National Center for PTSD, Veterans Affairs Medical Center, White River Junction, VT
8 Senior Advisor, National Center for PTSD, Veterans Affairs Medical Center, White River Junction, VT and Departments of Psychiatry, The Geisel School of Medicine at Dartmouth, Hanover, NH
Corresponding author and address for reprints: Dr. Nancy Bernardy, National Center for PTSD (116D), White River Junction VA Medical Center, 215 North Main, White River Junction, VT 05001, phone 802/296-5132, fax 802/296-5135, Nancy.Bernardy@va.gov
Abstract count 251
Word count 4325
3 Tables